Abstract:Background: Eosinophilic esophagitis (EoE) is recognized as a chronic type 2 inflammatory disease characterized by the eosinophilic infiltration of the esophageal tissue, posing a significant disease burden and highlighting the necessity for novel management strategies to address unmet clinical needs. Objectives: To critically evaluate the existing literature on the epidemiology and management of EoE, identify evidence gaps, and assess the efficacy of current and emerging treatment modalities. Design: An extensive literature review was conducted, focusing on the epidemiological trends, diagnostic challenges, and therapeutic interventions for EoE. This was complemented by a survey among physicians and consultations with a scientific expert panel, including a patient's association (ESEO Italia), to enrich the study findings. Data sources and methods: The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, scrutinizing epidemiological studies and management research to compile comprehensive insights into the disease's landscape. The physician survey and expert panel discussions aimed to bridge identified evidence gaps. Results: The review included 59 epidemiological and 51 management studies, uncovering variable incidence and prevalence rates of EoE globally, with an estimated diagnosed prevalence of 41 per 100,000 in Italy. Diagnostic challenges were identified, including nonspecific symptoms and the lack of definitive biomarkers, which complicate the use of endoscopy. Treatment options such as elimination diets, proton-pump inhibitors, and swallowed corticosteroids were found to have varying success rates, while Dupilumab, an emerging therapy targeting interleukin (IL)-4 and IL-13, shows promise. Conclusion: Despite advancements in understanding and managing EoE, significant unmet clinical needs remain, particularly in biomarker identification, therapy personalization, and cost-effectiveness evaluation. A comprehensive, multidimensional approach to patient management is required, emphasizing the importance of early symptom recognition, accurate diagnosis, and tailored treatment strategies. Dupilumab offers potential as a novel treatment, underscoring the need for future research to explore the economic and social dimensions of EoE care pathways.

Eosinophilic esophagitis and the promise of vitamin D

Vitamin D Levels as a Potential Modifier of Eosinophilic Esophagitis Severity in Adults

Serum vitamin D levels in a cohort of adult and pediatric patients with eosinophilic esophagitis

Impact of vitamin D deficiency on increased blood eosinophil counts

Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations

Vitamin D and the Pathogenesis of Inflammatory Bowel Disease

Dietary Management of Eosinophilic Esophagitis

Vitamin D and the development of allergic disease: how important is it?

Eosinophilic Esophagitis and Microbiota: State of the Art

Mucosal vitamin D signaling in inflammatory bowel disease

An esophagus cell atlas reveals dynamic rewiring during active eosinophilic esophagitis and remission

Exploring the Role of Vitamin D and the Vitamin D Receptor in the Composition of the Gut Microbiota

Contemporary Perspectives on the Role of Vitamin D in Enhancing Gut Health and Its Implications for Preventing and Managing Intestinal Diseases

Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome

An update on Eosinophilic Esophagitis

Vitamin D constrains inflammation by modulating the expression of key genes on Chr17q12-21.1

Targeted Therapies for Eosinophilic Gastrointestinal Disorders

Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier

Eosinophilic esophagitis in adults and adolescents: epidemiology, diagnostic challenges, and management strategies for a type 2 inflammatory disease

Dietary composition of adult eosinophilic esophagitis patients is related to disease severity

Vitamin D and the microbiota connection: understanding its potential to improve COPD outcomes